Patients with hereditary retinoblastoma carry a germline mutation in the RB1 gene and are at substantially increased risk of subsequent malignant neoplasms (SMNs) compared to patients with nonhereditary retinoblastoma and to the general population [1,2,3,4]. The gene discussed is RB1; the disease is retinoblastoma.